Drug concentrations and anti-drug antibodies during treatment with biosimilar infliximab (CT-P13) in routine care

B Glintborg, T Kringelbach, N Bolstad, D J Warren, G Eng, I J Sørensen, A G Loft, O Hendricks, Imj Hansen, A Linauskas, H Nordin, S Kristensen, H Lindegaard, D V Jensen, G L Goll, E Høgdall, J Gehin, C Enevold, C H Nielsen, N S KroghJ S Johansen, M L Hetland

Research output: Contribution to journalLetterpeer-review

8 Citations (Scopus)
Original languageEnglish
JournalScandinavian Journal of Rheumatology
Issue number5
Pages (from-to)418–421
Number of pages4
Publication statusPublished - 2018


  • Adult
  • Aged
  • Antibodies, Monoclonal/blood
  • Antibodies/blood
  • Arthritis/blood
  • Denmark
  • Female
  • Follow-Up Studies
  • Humans
  • Infliximab/administration & dosage
  • Male
  • Middle Aged

Cite this